Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats

Kidney International

Volumn 69, Issue 11, 2006, Pages 2013-2021

  Jacobi, J ^a   Porst, M ^a   Cordasic, N ^a   Namer, B ^a   Schmieder, R E ^a   Eckardt, K U ^a   Hilgers, K F ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Nephrologische Forschungslabors   (Germany)

Author keywords

Angiogenesis; Capillary; Chronic kidney failure; Ischemia; Perfusion; Skeletal muscle

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN; MESSENGER RNA; MICROSPHERE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADAPTATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL; CAPILLARY DENSITY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; HINDLIMB; KIDNEY ISCHEMIA; LASER DOPPLER FLOWMETRY; MALE; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UREMIA;

ANIMALS; HINDLIMB; ISCHEMIA; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 33745245552     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000448     Document Type: Article

References (37)

1. O'Hare AM, Bertenthal D, Shlipak MG et al. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2005; 16: 514-519.
2. O'Hare AM, Glidden DV, Fox CS et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004; 109: 320-323.
3. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
4. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152.
5. Yancopoulos GD, Davis S, Gale NW et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
6. Amann K, Neimeier KA, Schwarz U et al. Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle. Am J Kidney Dis 1997; 30: 382-388.
7. Amann K, Breitbach M, Ritz E et al. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
8. Sakkas GK, Ball D, Mercer TH et al. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dial Transplant 2003; 18: 2074-2081.
9. Sakkas GK, Ball D, Sargeant AJ et al. Skeletal muscle morphology and capillarization of renal failure patients receiving different dialysis therapies. Clin Sci (London) 2004; 107: 617-623.
10. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
11. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065.
12. Pinkau T, Hilgers KF, Veelken R et al. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? J Am Soc Nephrol 2004; 15: 517-523.
13. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434-1447.
14. Kang DH, Hughes J, Mazzali M et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001; 12: 1448-1457.
15. Herbrig K, Pistrosch F, Oelschlaegel U et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849.
16. Harper SJ, Downs L, Tomson CR et al. Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia. Nephron 2002; 90: 341-343.
17. Hoefer IE, van Royen N, Rectenwald JE et al. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 2002; 105: 1639-1641.
18. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003; 23: 1143-1151.
19. Bagi Z, Hamar P, Antus B et al. Chronic renal failure leads to reduced flow-dependent dilation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Pressure Res 2003; 26: 19-26.
20. Passauer J, Pistrosch F, Bussemaker E et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol 2005; 16: 959-965.
21. London GM, Pannier B, Agharazii M et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int 2004; 65: 700-704.
22. Vallance P, Leone A, Calver A et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
23. Zoccali C, Bode-Boger S, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113-2117.
24. Jacobi J, Sydow K, von Degenfeld G et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 2005; 111: 1431-1438.
25. Ivanovski O, Szumilak D, Nguyen-Khoa T et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 2005; 67: 2288-2294.
26. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567.
27. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833.
28. Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926.
29. de Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646.
30. Eizawa T, Murakami Y, Matsui K et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003; 19: 627-633.
31. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252.
32. Ziegelhoeffer T, Fernandez B, Kostin S et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004; 94: 230-238.
33. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 1994; 4: 2023-2031.
34. Jacobi J, Tam BY, Wu G et al. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia. Circulation 2004; 110: 2424-2429.
35. Fullerton A, Stucker M, Wilhelm KP et al. Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Standardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European community project. Contact Dermatitis 2002; 46: 129-140.
36. Buschmann IR, Hoefer IE, van Royen N et al. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 2001; 159: 343-356.
37. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532-534, 536-537.